Last reviewed · How we verify
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis
This is a phase I trial investigating the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) using paclitaxel combined with intravenous FOLFOX therapy for gastric cancer patients with peritoneal metastasis.
Details
| Lead sponsor | Seoul National University Bundang Hospital |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 18 |
| Start date | Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Jun 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Stomach Neoplasm
- Peritoneal Metastases
Interventions
- Pressurized Intraperitoneal Aerosol Chemotherapy
Countries
South Korea